For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab51132? Please let us know so that we can cite the reference in this datasheet.
ab51132 has been referenced in 2 publications.
- Zeng J et al. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy. Theranostics 8:109-123 (2018).
- Shields BB et al. A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression. Mol Syst Biol 11:842 (2015).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"